The World Anesthesia Drug Market

26 Nov 2010 • by Natalie Aster

New York – Although the anesthesia market is rather mature, it continues to expand, with growth driven by more surgeries as a result of an aging population. According to Kalorama Information's analysis in their updated report - The World Anesthesia Drug Market - new therapeutic applications, including a potential treatment for depression may drive additional sales long-term. The latest report focuses on three primary anesthesia segments:

  • General Anesthesia;
  • Local Anesthesia;
  • Adjunctive Therapies in Anesthesia.

Report Details: 

The World Anesthesia Drug Market
Date: April 2010
Pages: 180
Price: US$ 3,995.00

Report Sample Abstract:

Kalorama Information expects the general anesthesia segment to enjoy the highest annual growth at 4.8% through 2014. Revenues for each segment were generated using dollar and unit sales for each product. The report covers both currently marketed and late stage development anesthesia drugs in detail. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors.

The World Anesthesia Drug Market” includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide the following:

  • Market Overview;
  • Description of Products on the Market;
  • Description of Products in Development;
  • Market Estimates and Forecasts;
  • Competitive Analysis of Leading Providers;
  • Current Issues and Trends Affecting the Industry.

More information is available in the report “The World Anesthesia Drug Market” by Kalorama Information.

To order the report or ask for free sample pages contact


MarketPublishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 123 2220
Fax: +44 207 900 3970